MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis |
Wang, Zhiguo
(Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University)
Luo, Hong (Department of Hematology, the First Hospital of Qiqihar) Fang, Zehui (Department of Endocrinology, the 4th Affiliated Hospital of Harbin Medical University) Fan, Yanling (Department of Bone Marrow Transplantation, Harbin Hematological Cancer Institute, Harbin the First Hospital) Liu, Xiaojuan (Department of Bone Marrow Transplantation, Harbin Hematological Cancer Institute, Harbin the First Hospital) Zhang, Yujing (Department of Endocrinology, the 4th Affiliated Hospital of Harbin Medical University) Rui, Shuping (Department of Bone Marrow Transplantation, Harbin Hematological Cancer Institute, Harbin the First Hospital) Chen, Yafeng (Department of Bone Marrow Transplantation, Harbin Hematological Cancer Institute, Harbin the First Hospital) Hong, Luojia (Department of Endocrinology, the 4th Affiliated Hospital of Harbin Medical University) Gao, Jincheng (Department of Endocrinology, the 4th Affiliated Hospital of Harbin Medical University) Zhang, Mei (Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University) |
1 | Fulda S (2014) Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities. Leukemia 28, 1414-1422 DOI |
2 | Chen Z, Naito M, Hori S, Mashima T, Yamori T and Tsuruo T (1999) A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun 264, 847-854 DOI |
3 | Martin SJ (2004) An Apollon vista of death and destruction. Nat Cell Biol 6, 804-806 DOI |
4 | Ismail EA, Mahmoud HM, Tawfik LM et al (2012) BIRC6/Apollon gene expression in childhood acute leukemia: impact on therapeutic response and prognosis. Eur J Haematol 88, 118-127 DOI |
5 | Sung KW, Choi J, Hwang YK et al (2007) Overexpression of Apollon, an antiapoptotic protein, is associated with poor prognosis in childhood de novo acute myeloid leukemia. Clin Cancer Res 13, 5109-5114 DOI |
6 | Lopergolo A, Pennati M, Gandellini P et al (2009) Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. Br J Cancer 100, 739-746 DOI |
7 | Tang W, Xue R, Weng S et al (2015) BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation. Int J Cancer 136, E475-487 DOI |
8 | Shrestha S, Yang CD, Hong HC et al (2017) Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A. Int J Mol Sci 19 |
9 | Shu Y, Ren L, Xie B, Liang Z and Chen J (2017) MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway. Oncotarget 8, 97313-97322 |
10 | Song CJ, Chen H, Chen LZ, Ru GM, Guo JJ and Ding QN (2017) The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies. J Cell Biochem 119, 2763-2786 |
11 | Zhu X, Shen H, Yin X et al (2017) IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells. Oncotarget 8, 39154-39166 |
12 | Yin Y, Zhang B, Wang W et al (2014) miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. Clin Cancer Res 20, 6187-6199 DOI |
13 | Duan S, Wu A, Chen Z, Yang Y, Liu L and Shu Q (2017) MiR-204 Regulates Cell Proliferation and Invasion by Targeting EphB2 in Human Cervical Cancer. Oncol Res 26, 713-723 |
14 | Diaz-Martinez M, Benito-Jardon L, Alonso L, Koetz-Ploch L, Hernando E and Teixido J (2017) miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma. Cancer Res 78, 1017-1030 |
15 | Luo YH, Tang W, Zhang X et al (2017) Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma. Medicine (Baltimore) 96, e7545 DOI |
16 | Reubold TF and Eschenburg S (2012) A molecular view on signal transduction by the apoptosome. Cell Signal 24, 1420-1425 DOI |
17 | Li T, Pan H and Li R (2016) The dual regulatory role of miR-204 in cancer. Tumour Biol 37, 11667-11677 DOI |
18 | Roldo C, Missiaglia E, Hagan JP et al (2006) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24, 4677-4684 DOI |
19 | Jin Z and El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4, 139-163 |
20 | Zanette DL, Rivadavia F, Molfetta GA et al (2007) miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 40, 1435-1440 DOI |
21 | Chu L, Gu J, Sun L, Qian Q, Qian C and Liu X (2008) Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil. Gene Ther 15, 484-494 DOI |
22 | Choi H, Lee H, Kim SR, Gho YS and Lee SK (2013) Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol 87, 8135-8144 DOI |
23 | Crippa E, Folini M, Pennati M, Zaffaroni N, Pierotti MA and Gariboldi M (2016) miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells. Oncotarget 7, 18594-18604 |
24 | Druz A, Chu C, Majors B, Santuary R, Betenbaugh M and Shiloach J (2011) A novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells. Biotechnol Bioeng 108, 1651-1661 DOI |
25 | Van Houdt WJ, Emmink BL, Pham TV et al (2011) Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target. Mol Cell Proteomics 10, M111 011353 DOI |
26 | Bartke T, Pohl C, Pyrowolakis G and Jentsch S (2004) Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol Cell 14, 801-811 DOI |
27 | Okumu DO, East MP, Levine M et al (2017) BIRC6 mediates imatinib resistance independently of Mcl-1. PLoS One 12, e0177871 DOI |
![]() |